News more>>
  11/14/2014    | BeiGene Completes 450 Million RMB (75 Million USD) Financing
  11/11/2014    | Dr. Jason Yang, Senior Vice President of Clinical Development spoke at ChinaTrials 7 Summit
  10/10/2014    | BeiGene Wins BEEA Science and Technology Innovation Award
  09/26/2014    | Dr. Lusong Luo spoke at EFPIA public conference
  09/15/2014    | BeiGene Receives Clinical Milestone Payment for Development of BGB-290
  09/04/2014    | Alice Tian and Na Li Recieved "Beijing overseas high-caliber talents" Award
  09/03/2014    | Boehringer Ingelheim and BeiGene Announce Strategic Supply and Manufacturing Agreement in China
  08/27/2014    | BeiGene Expands Management Team with Two Strategic Senior Positions
  08/26/2014    | BeiGene Enrolls First Patient in Phase 1 Study of BGB-3111
  07/08/2014    | BeiGene Enrolls First Patient in Phase 1 Study of BGB-290
07/01/2014    | BeiGene Wins "The best investment value Top 10 company in Chinese pharmaceutical industry 2014"
  06/30/2014    | Dr. Lusong Luo is invited to present in the National gastric cancer conference in Beijing
06/04/2014    | BeiGene speaks at BOSTON BIOTECH CEO CONFERENCE
05/07/2014    | Dr.Xiaodong Wang was selected as associate members of EMBO
05/05/2014    | BeiGene Receives $5 Million Clinical Milestone Payment for Development of BGB-283
03/18/2014    | CNCBD (China National Center for Biotechnology Development) Director Huang Jing visited BeiGene on Mar 13, 2014
03/10/2014    | BeiGene Announces Presentations at AACR Annual Meeting 2014
03/03/2014    | BeiGene Announces Addition of Dr. Ronald Levy to Scientific Advisory Board
01/22/2014    | BJDA Deputy Director Luoluo Cong visit BeiGene
01/15/2014    | BeiGene selected as a Z-Park Top 10 up-and-coming company
Copyright BeiGene LTD    |   Careers   |    Contact Us
 京ICP备13047662号